Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma

BACKGROUND: Cardiovascular toxicity is a notorious complication of doxorubicin (DXR) therapy for diffuse large B-cell lymphoma (DLBCL). Although surveillance of well-known biological markers for cardiovascular disease (CVD) as NTproBNP and Troponins may be helpful, there are no established markers t...

Descripción completa

Detalles Bibliográficos
Autores principales: Mörth, Charlott, Sabaa, Amal Abu, Freyhult, Eva, Christersson, Christina, Hashemi, Jamileh, Hashemi, Nashmil, Kamali-Moghaddam, Masood, Molin, Daniel, Höglund, Martin, Eriksson, Anna, Enblad, Gunilla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856776/
https://www.ncbi.nlm.nih.gov/pubmed/33536059
http://dx.doi.org/10.1186/s40959-021-00092-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856776/
https://www.ncbi.nlm.nih.gov/pubmed/33536059
http://dx.doi.org/10.1186/s40959-021-00092-0

Ejemplares similares